Bio-Rad Laboratories (BIO) Total Liabilities (2009 - 2026)

Bio-Rad Laboratories (BIO) has reported Total Liabilities for 18 consecutive years, with $3.1 billion the latest figure, recorded in Q2 2026.

• On a quarterly basis, Total Liabilities changed 0.24% year-over-year to $3.1 billion in Q2 2026; TTM through Jun 2026 was $3.1 billion, a 0.24% change from a year earlier, with the FY2025 full-year figure at $3.1 billion, up 11.74% from the prior year.
• Total Liabilities was $3.1 billion for Q2 2026 at Bio-Rad Laboratories, up from $2.9 billion in the prior quarter.
• Over five years, Total Liabilities peaked at $4.2 billion in Q1 2022 and troughed at $2.8 billion in Q4 2024.
• A 5-year average of $3.4 billion and a median of $3.3 billion in 2023 frame the typical range for Total Liabilities.
• The widest YoY moves for Total Liabilities: up 26.07% in 2022, down 21.99% in 2022.
• Over 5 years, Total Liabilities stood at $3.9 billion in 2022, then fell by 8.45% to $3.6 billion in 2023, then fell by 21.45% to $2.8 billion in 2024, then gained by 11.74% to $3.1 billion in 2025, then decreased by 1.43% to $3.1 billion in 2026.
• The last three Total Liabilities figures came in at $3.1 billion (Q2 2026), $2.9 billion (Q1 2026), and $3.1 billion (Q4 2025), per Business Quant data.